Sabotage as therapy: Aiming lupus antibodies at vulnerable cancer cells
Yale Cancer Center researchers may have discovered a new way of harnessing lupus antibodies to sabotage cancer cells made vulnerable by deficient DNA repair.
Sep 2, 2014
0
0
Yale Cancer Center researchers may have discovered a new way of harnessing lupus antibodies to sabotage cancer cells made vulnerable by deficient DNA repair.
Sep 2, 2014
0
0
Higher intake of omega-3 fatty acids was associated with better sleep quality and a decrease in depressive symptoms in lupus patients, among other patient-reported outcomes, according to new research findings presented this ...
Nov 5, 2017
1
31
(HealthDay)—The microbiome of patients with systemic lupus erythematosus (SLE), particularly those with increased disease activity, has reduced taxonomic complexity, according to a study published online Feb. 19 in the ...
Feb 20, 2019
1
3
People with lupus, an autoimmune disease, suffer from fatigue, joint pain and swelling and also have a markedly increased risk of developing osteoporosis. Clinical trials have shown that receiving a transplant of mesenchymal ...
Oct 26, 2015
0
197
UC Davis Health researchers have dosed the second participant in their clinical trial looking to identify a potential cure for HIV utilizing CAR T-cell therapy. The novel study uses immunotherapy. It involves taking a patient's ...
Apr 19, 2023
0
8
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 have shown a link between newly-diagnosed Sjögren's syndrome (SjS) and previous infection with nontuberculous mycobacteria ...
Jun 15, 2017
0
42
Researchers at Michigan Medicine have uncovered the molecular mechanism that drives the disease-causing effects of the most common genetic risk factor for lupus, a study suggests.
Aug 18, 2022
0
86
Three newly confirmed lupus genes are opening new avenues of research at the Oklahoma Medical Research Foundation.
Mar 29, 2012
0
0
Some genetic variants may put people at risk of autoimmune diseases while conferring protection against the outcome of viral infection. A study published November 3 in the open access journal PLOS Genetics by David Morris ...
Nov 3, 2022
0
30
New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, discovers that use of hydroxychloroquine, a generic drug, does not cause any significant differences in QTc length or prolonged ...
Nov 6, 2020
0
3